THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation CONTINUED ACCESS

PHASE3CompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

July 1, 2012

Primary Completion Date

June 1, 2014

Study Completion Date

October 1, 2014

Conditions
Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Interventions
DEVICE

THERMOCOOL® SMARTTOUCH™ Catheter

AF Ablation

Trial Locations (20)

10029

Mt. Sinai School of Medicine, New York

19104

University of Pennslyvania, Philadelphia

21287

Johns Hopkins Hospital, Baltimore

23219

Virginia Commonwealth University, Richmond

27710

Duke University Medical Center, Durham

30309

Piedmont Heart Institute, Atlanta

32803

Florida Hospital, Orlando

35294

University of Alabama, Birmingham, Birmingham

43210

Ohio State University, Columbus

44195

Cleveland Clinic Foundation, Cleveland

55407

Abbott Northwestern Hospital, Minneapolis

55902

Mayo Clinic, Rochester

60153

Loyola University Chicago, Maywood

66160

University of Kansas Hospitals, Kansas City

73104

University of Oklahoma, Oklahoma City

78705

Texas Cardiac Arrhythmia Foundation, Austin

94305

Stanford University School of Medicine, Stanford

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Boston

07450

The Valley Hospital, Ridgewood

All Listed Sponsors
lead

Biosense Webster, Inc.

INDUSTRY

NCT01639495 - THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation CONTINUED ACCESS | Biotech Hunter | Biotech Hunter